Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.
about
CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.Treatment of refractory juvenile chronic arthritis by monoclonal CD4 antibodies: a pilot study in two childrenFrom bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies.Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology.Cell therapy for autoimmune diseasesPharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets.Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis.Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.Monoclonal antibodies in the treatment of rheumatoid arthritis.A review on the strategies for the development and application of new anti-arthritic agents.The use of biologics in the treatment of rheumatoid arthritis (RA)--the good news and the bad news.Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients.[Pathogenic cells of rheumatic inflammation as the target of modern therapies].
P2860
Q24515348-147216B2-0492-481B-9197-BD38154BB209Q33578439-1C47AF56-D8C6-4C7B-BAED-74C8EE686F64Q34321820-040A303B-5D31-4B96-8DFF-8B8E400F6B7AQ35548626-3CF43645-0660-4CED-A5AD-612A44AAB555Q35868954-E137420B-B53D-4E67-AD6E-68349EB951DDQ37781913-DC1841B6-4BBF-4198-9779-6DDAFBCE5CFAQ38203622-A15A20C7-320A-4FCC-A5DC-8F827A886A45Q39452477-283C3826-6C96-49EA-BAF4-EF2B6375D8DFQ40396183-744B50D1-A262-450A-B784-78D4B258F8A0Q40693747-6A77B4EB-B646-44C9-BC1D-1894E816ABF6Q40932806-E0E70106-8027-4219-811C-76D80B0B7C7EQ41465945-B598ED9C-CAD5-439D-963F-B9D45707F188Q42635758-CE3C6F8F-0278-4ADB-A0BB-E4E846AA20AEQ53610953-61E647AC-FC3E-4586-919D-21EABA9B4EC9
P2860
Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Use of a chimeric monoclonal a ...... fractory rheumatoid arthritis.
@en
type
label
Use of a chimeric monoclonal a ...... fractory rheumatoid arthritis.
@en
prefLabel
Use of a chimeric monoclonal a ...... fractory rheumatoid arthritis.
@en
P2093
P356
P1476
Use of a chimeric monoclonal a ...... fractory rheumatoid arthritis.
@en
P2093
Everson MP
Khazaeli M
Kilgarriff C
LoBuglio AF
Moreland LW
P304
P356
10.1002/ART.1780360304
P577
1993-03-01T00:00:00Z